We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.6B
AUM Growth
+$166M
(+0.47%)
Cap. Flow
+$350M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
19.85%
Holding
1,363
New
118
Increased
473
Reduced
442
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$76.2M |
| 2 |
S&P Global
SPGI
|
+$73M |
| 3 |
Adobe
ADBE
|
+$62.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$56.5M |
| 5 |
NVIDIA
NVDA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$60.1M |
| 2 |
Colgate-Palmolive
CL
|
+$57.1M |
| 3 |
Cisco
CSCO
|
+$55.2M |
| 4 |
Generac Holdings
GNRC
|
+$44.8M |
| 5 |
Alibaba
BABA
|
+$42.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.95% |
| 2 | Healthcare | 17.81% |
| 3 | Consumer Discretionary | 11.77% |
| 4 | Financials | 10.45% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
551
DELISTED
Perficient Inc
PRFT
| $7.68M | 0.02% |
66,400
+16,600
| +33% | +$1.71M |
|
552
Sun Life Financial
SLF
$45B
| $7.68M | 0.02% |
149,276
+4,280
| +3% | +$220K |
|
553
Boyd Gaming
BYD
$5.56B
| $7.67M | 0.02% |
121,200
+14,100
| +13% | +$836K |
|
554
Novavax
NVAX
$1.53B
| $7.63M | 0.02% |
36,827
+1,356
| +4% | +$299K |
|
555
SS&C Technologies
SSNC
$19B
| $7.5M | 0.02% |
108,068
+7,411
| +7% | +$549K |
|
556
Alkami Technology
ALKT
$2.03B
| $7.48M | 0.02% |
303,129
+103,129
| +52% | +$3.07M |
|
557
Factset
FDS
$9.77B
| $7.41M | 0.02% |
18,757
| – | – |
|
558
ManpowerGroup
MAN
$2.69B
| $7.36M | 0.02% |
68,000
+3,399
| +5% | +$396K |
|
|
BHVN
559
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.28M | 0.02% |
52,391
+10,460
| +25% | +$1.31M |
|
560
Lufax Holding
LU
$1.06B
| $7.27M | 0.02% |
260,342
+37,223
| +17% | +$1.24M |
|
561
Avnet
AVT
$7.72B
| $7.24M | 0.02% |
195,700
-29,500
| -13% | -$1.17M |
|
562
Builders FirstSource
BLDR
$6.58B
| $7.18M | 0.02% |
138,787
-24,700
| -15% | -$1.21M |
|
563
Revvity
RVTY
$16.3B
| $7.12M | 0.02% |
41,095
-95,368
| -70% | -$16.8M |
|
564
Kulicke & Soffa
KLIC
$4.21B
| $7.11M | 0.02% |
122,000
+115,700
| +1,837% | +$7.2M |
|
565
IDEAYA Biosciences
IDYA
$3.65B
| $7.11M | 0.02% |
278,733
+38,626
| +16% | +$902K |
|
566
United Therapeutics
UTHR
$21.6B
| $7.07M | 0.02% |
38,293
+17,800
| +87% | +$3.51M |
|
567
PVH
PVH
$3.39B
| $7.03M | 0.02% |
68,400
+3,800
| +6% | +$409K |
|
568
Essex Property Trust
ESS
$17.6B
| $7.01M | 0.02% |
21,938
-67
| -0.3% | -$21.7K |
|
569
Rambus
RMBS
$8.94B
| $7M | 0.02% |
315,100
| – | – |
|
570
Sun Communities
SUI
$14.1B
| $6.96M | 0.02% |
37,572
+16,577
| +79% | +$3.2M |
|
571
MGP Ingredients
MGPI
$309M
| $6.93M | 0.02% |
106,497
+53,114
| +99% | +$3.4M |
|
572
Enphase Energy
ENPH
$4.7B
| $6.9M | 0.02% |
46,000
+17,183
| +60% | +$2.95M |
|
573
Agnico Eagle Mines
AEM
$101B
| $6.89M | 0.02% |
132,942
+12,193
| +10% | +$710K |
|
|
SWTX
574
DELISTED
SpringWorks Therapeutics
SWTX
| $6.84M | 0.02% |
107,796
+3,972
| +4% | +$306K |
|
575
Penske Automotive Group
PAG
$14.2B
| $6.83M | 0.02% |
67,900
+11,000
| +19% | +$965K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q3 2021 Portfolio in Review
As of Q3 2021, Axa held 1,363 positions worth $35.6B, up 0.47% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa's Q3 2021 filing shows 118 new, 473 increased, 442 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 575,960 shares worth $45.2M. The largest sale was Bank of New York Mellon, an estimated $60.1M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q3 2021 buy was GXO Logistics: 575,960 shares worth $45.2M.
- Axa added most to AT&T in Q3 2021, an estimated $76.2M increase.
- Axa's biggest Q3 2021 reduction was Bank of New York Mellon, cutting an estimated $60.1M.
- Axa fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $35.3M.
- Axa's ten largest holdings make up 20% of its $35.6B portfolio in Q3 2021.
- Axa opened 118 new positions and closed 143 in Q3 2021.
- Axa's portfolio value rose 0.47% quarter-over-quarter to $35.6B.
Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.